Liposomal Omega

Omega-3 fatty acids, particularly DHA and EPA, are among the most researched nutrients in the world, with over 25,000 studies published to date. The science is not only solid, it’s still evolving. Research continues to unlock new applications, from cellular health to advanced clinical uses. While debates around plant-based or algae-derived omega-3s versus traditional fish oil continue, the bigger issue remains unchanged: most people simply aren’t getting enough DHA and EPA in their diets.

As an industry and moreover as science-led innovators, we have a responsibility to make omega-3s more bioavailable.

These essential fatty acids fuel the health of your heart, brain and eyes - foundational organs that impact every stage of life. While omega-3s are well-established for their roles in maternal and cognitive health, it's their powerful cardiovascular benefits that the World Health Organisation flags as most urgent, given heart disease remains a leading global killer.

Put simply: DHA and EPA aren’t just nice to have, they’re non-negotiable for long-term health.

When it comes to cardiovascular wellbeing, few nutrients are backed by as much robust clinical evidence as DHA and EPA. These omega-3 powerhouses have been at the forefront of heart health research for decades and the science continues to hold.

In fact, since 2013, the European Union has authorised the following health claims under Article 13 of the Nutrition and Health Claims Regulation (NHCR):

+ DHA helps maintain normal blood triglyceride levels.
+ DHA and EPA support the maintenance of normal triglyceride concentrations.
+ DHA and EPA contribute to normal blood pressure.

Elevated triglycerides, which are the fats in your bloodstream, can lead to thickening of arterial walls, a key risk factor in heart disease. DHA and EPA actively help to reduce these triglyceride levels, lowering cardiovascular risk in the process.

Omega-3s don’t just support heart health, they help protect it. It's why they remain essential in any discussion about preventing cardiovascular disease, still the world’s number one cause of death.

lipolife® deliver DHA and EPA in liposomal form to maximise bioavailability, so your heart gets the support it truly needs.

A deficiency in omega-3 fatty acids, especially EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), can manifest in a range of physical and cognitive symptoms. These symptoms occur because omega-3s are essential for cellular function, particularly in the brain, eyes, skin and cardiovascular system.

Some key characteristics of omega deficiency may manifest as follows:

+ Cognition - Brain fog, poor concentration, mood swings, anxiety or depression.
+ Skin health - Rough, scaly skin, increased sensitivity or dermatitis, slow wound healing and increased inflammation.
+ Eye health - Blurred vision or dry eyes.
+ Joint pain or stiffness.
+ Cardiovascular health - High blood pressure, elevated triglyceride levels.

If you suspect an omega-3 deficiency, testing via blood (such as an Omega-3 Index test) can help determine your status. Supplementation or dietary changes - increasing intake of fatty fish, flaxseed, walnuts or algae oil - are often recommended.

The NHS recommend a healthy, balanced diet should include at least 2 portions of fish a week, including 1 of oily fish. This is due to oily fish being particularly high in long-chain omega-3 fatty acids which are essential for heart health. If your diet is plant-based, foods that have omega-3 added or supplements should be considered. Aim to get 500mg of EPA and DHA combined each day as this works out similar to a 140g portion of oily fish per week.